issued
on 19 Nov 2024
Last Applicant/ Owned by
9880 Campus Point Drive, Suite 210
San Diego
CA
92121
Serial Number
98143320 filed on 21st Aug 2023
Registration Number
N/A
Correspondent Address
Samantha C. Markley
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, genetic Read More
Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings
N/A
N/A
Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, genetic imaging devices and analyzers for genetic analysis
N/A
N/A
Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; instruments for scientific use, namely, nucleic acid sequencers, genetic imaging devices and analyzers for genetic analysis
N/A
N/A
Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for use in diagnostic tests for medical purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use
N/A
N/A
Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for laboratory research use; diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for diagnostic laboratory purposes
N/A
N/A
No 98143320
No Service Mark
No ELEM-222
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
19th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
08th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
08th Oct 2024 | PUBLISHED FOR OPPOSITION |
18th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
30th Aug 2024 | EXAMINERS AMENDMENT E-MAILED |
30th Aug 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
30th Aug 2024 | EXAMINERS AMENDMENT -WRITTEN |
30th Aug 2024 | EXAMINER'S AMENDMENT ENTERED |
30th Aug 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
12th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |